Home >> Staff >> Prof Habib - Short Form CV adobeThis page can be downloaded as a PDF file. You will need Adobe Reader to view it, which can be downloaded by clicking on the Adobe image.
 
Curriculum Vitae
Professor Nagy A. Habib ChM FRCS		 habibcv

Liver Surgery Section.
Department of Cancer Surgery Division of Surgery,
Oncology, Reproduction & Anaesthetics,
Imperial College London,
1st Floor B Block,
Hammersmith Hospital Campus,
Du Cane Road,
London W12 0NN, UK.
Tel: +44 (020 8383 8574
Fax: +44 (0)20 8383 3212
e-mail: nagy.habib@imperial.ac.uk

 

Nationality

Egyptian and British (dual)


Languages

English, French and Arabic.


Major Research Interests

Improvement and amplification of surgical technologies.

Remediation and/or cure of diseases of the liver as either an adjunct or instead of surgery with particular attention to gene therapy, the use of stem cells and immunotherapy.


Formal Education

Academic Qualifications   Academic Body   Date Awarded
MB, BCh
  Ein-Shams University   February 1977
FRCS
   Primary FRCS   June 1978
FRCS Ed
  Edinburgh RCS   November 1981
ChM
   Bristol University   January 1988
Higher Surgical Training
  Edinburgh RCS   January 1989


Registration

Full registration (GMC) No 2814849


Medical Protection

Member of the Medical Protection Society Limited , No 118703


Membership of Scientific Societies

  • European Association for Cancer Research (EACR).
  • International Society for Oncodevelopment Biology and Medicine (ISOBM).
  • International Society of Preventive Oncology (ISPO).
  • Pancreatic Society of Great Britian and Ireland.
  • UK Chapter of World Association of Hepatopancreatobiliary Surgery.
  • Surgical Research Society (SRS).
  • British Society of Gastroenterology.
  • British Transplantation Society.
  • British Association for Cancer Research.
  • Association of Surgeons of Great Britain and Ireland.
  • European Liver Transplant Association (ELTA)
  • British Association of Surgical Oncology, (BASO)
  • Member of American Association of Cancer Research (Membership No. 14947)
  • Member of Board of Directors of European Society for Engineering & Medicine (ESEM )
  • Member of the World Academy of Science
  • Secretary General, International Society of Cancer Gene Therapy


Editorial Board Membership

  • Cancer Gene Therapy
  • Cancer Biology and Therapy
  • Health Care Technology

Editorial Review Panels

  • Annals of the Royal College of Surgeons of Edinburgh
  • Annals of the Royal College of Surgeons of England
  • European Journal of Cancer


Occasional review papers for

  • British Journal of Surgery
  • The Lancet
  • British Journal of Cancer.
  • Gut


Patents

Professor Habib has taken out, and is deploying, a number of active patents. In some instances these patents are in conjunction with his Academic partner, Imperial College.


Commercial Spin Off Companies

EMcision Limited

OmniCyte Limited


External collaborations

CNRS, Faculte de Medcine RTH Laennec, Lyons, France, Professor Pierre Boulanger

Tohoku University School of Medicine, Sendai, Japan, Professor Makoto Sunamura

Universite Louis Pasteur, Strasbourg, France, Professor Daniel Jaeck

University of Toulouse, France, Professor Jean-Gerard Tiraby

University of California Los Angeles, Professor Nori Kasahara

King’s College London, Professor Farzin Farzaneh

Faculty of Medicine RTH Laennec, Lyon, France, Professor Pierre Boulanger and Dr S S Hong

Got-A-Gene AB, Sweden, Professor Leif Lindholm

Institute of Digestive Diseases, Belgrade, Serbia & Montenegro, Professor Miroslav Milicevic

University of Messina, Sicily, Professor Giuseppe Navarra

Pietra Ligure, Italy (Ospedale Santa Corona), Professor Ricardo Pellici


External committees

British Society of Gene Therapy. Executive Board Member. 2002 - 2004
European Society for Engineering and Medicine. Member of Board of Directors. 1999
International Society of Cancer Gene Therapy. President. 2003 - 2004
International Association of Surgeons and Gastroenterologists. Board Member. 2005.


Guest lectures

Since 2001 Professor Habib has given 27 lectures by invitation at organizations throughout the world.


Industrial connections


Publications (summary with twelve selected major papers)

Professor Habib has published 216 peer reviewed papers, 38 papers by invitation, mainly as written form of a guest lecture, edited 6 books and written 23 book chapters. Twelve papers of particular import are as follows:-

Habib NA, CB Wood, K Apostolov, W Barker, MJ Hershman, M Aslam, D Heinemann, B Fermor, RCN Williamson, WE Jenkins, JRW Masters and MJ Embleton. Stearic acid and carcinogenesis. British Journal of Cancer, (1987), 56:455-458

Habib NA, D Houssin, C Carol, J Cardoso, C Boisseau, Y Calmus, Y Ozier, C Wood, N McIntyre. Experimental reduction of portal hypertension by mechanical increase of liver portal flow. The Lancet 1991;337:16 -17. Habib NA, Zografos G, Dalla Serra G, Greco L, Bean A. Liver resection for malignant tumours under total vascular exclusion. British Journal of Surgery, (1994), 81:1181-1184

Badia JM, Ayton LC, Evans TJ, Carpenter AJ, Nawfal G, Kinderman H, Zografos G, Uemoto S, Cohen J, Habib NA. The Systemic Cytokine Response to Liver Surgery Under Total Vascular Exclusion. European Journal of Surgery, (1998), 164:185-190

Jiao LR, Hansen PD, Havlik R, Habib NA. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumours. American Journal of Surgery, (1999), 117: 303-306

Tullo A, D'Erchia AM, Honda K, Mitry RR, Kelly MD, Habib NA, Saccone C, Sbisa E. Characterisation of p53 mutations in colorectal liver metastases and correlation with clinical parameters. Clinical Cancer Research, (1999), 5:3523-3528

Habib NA, Sarraf CE, Mitry RR, Havlik R, Nicholls J, Kelly M, Vernon CC, Gueret-Wardle D, El-Masry R, Salama H, Ahmed R, Michail N, Edward E, Jensen SL. E1B deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumours. Human Gene Therapy, (2001), 12:219-226

Mitry RR, Havlik R, Seth P, Hartwigsen J, Bhushan R, Nicholls JP, Jensen S, Habib NA. Clinical trial of E1B-deleted (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Therapy, (2002), 9:254-259

Weber J-C, Navarra G, Jiao LR, Nicholls J, Jensen S, Habib NA. New technique for liver resection using heat coagulative necrosis. Annals of Surgery, (2002), 236:560-563

Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A, Issa JP DNA methylation and environmental exposures in human hepatocellular carcinoma J Natl Cancer Inst, (2002), 94(10), 755-761

Hong SS, Habib NA, Franqueville L, Jensen S, Boulanger PA. Identification of adenovirus (Ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative Ad (Addl1520) for treatment of liver tumors. Journal of Virology, (2003), 77:10366-10375

Madhusudan S, Tamir A, Bates N, Flanagan E, Gore M, Barton D, Harper P, Seckl M, Thomas H, Lemoine N, Charnock M, Habib NA, Lechler R, Nicholls J, Pignatelli M, Ganesan T. A multicenter phase I gene therapy clinical trial involving intrapertioneal administration of E1A-lipd complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene. Clinical Cancer Research, (2004), 10:2986-2996

Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, M'Hamdi H, Thalji T, Welsh JP, Marley SB, J Davis, F Dazzi, F Marelli-Berg, P Tait, R Playforn, L Jiao, S Jensen, JP Nicholls, A Ayav, M Nohandani, F Farzaneh, J Gaken, R Dodge, M Alison, JF Apperley, R Lechler, NA Habib et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells, (2006), 24(7):1822-1830

 
(c) OmniCyte Ltd  
Web site by EnnJayBee